# Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)

> **NCT00854139** · PHASE1 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 10 (actual)

## Conditions studied

- Multiple Myeloma
- End Stage Renal Disease

## Interventions

- **DRUG:** Cyclophosphamide, anti-thymocyte globulin
- **PROCEDURE:** Kidney transplant
- **RADIATION:** Thymic irradiation
- **PROCEDURE:** Bone marrow transplant from a related donor

## Key facts

- **NCT ID:** NCT00854139
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00854139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00854139, "Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00854139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*